After the first generic enters the market, prices crash - but the real battle is just beginning. Learn how competitors enter, why authorized generics hurt first entrants, and how PBMs and patent tactics shape the future of generic drug pricing.
Learn MorePharmacists should recommend authorized generics for patients with allergies, narrow therapeutic index drugs, or those who react poorly to regular generics. These are identical to brand-name drugs, made by the same manufacturer, and offer safety and cost benefits.
Learn More